Monte Rosa Therapeutics Inc (GLUE)
Deferred Revenue
$22.10M
Quarterly · Period ending: · USD
GLUE Deferred Revenue
Latest reported$22.10Mperiod ending
Latest reported$22.10Mperiod ending
GLUE Quarterly Deferred Revenue ($0.00 → $22.10M)
Quarterly deferred revenue
High-resolution chart · PNG
GLUE deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 22,103,000 | |
| 33,059,000 | |
| 29,571,000 | |
| 24,791,000 | |
| 18,410,000 | |
| 32,575,000 | |
| 117,232,000 | |
| 18,918,000 | |
| 19,645,000 | |
| 20,407,000 | |
| 17,678,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |